Apr 13, 2021 Avenue Therapeutics Announces that the FDA is Still Reviewing Its NDA Resubmission for IV Tramadol
Dec 18, 2020 Avenue Therapeutics Announces Publication of Tramadol Non-Medical Use in Four European Countries: A Comparative Analysis
Dec 18, 2020 Avenue Therapeutics Announces Publication of Real-World Data on Nonmedical Use of Tramadol in ASI-MV Network
Aug 14, 2020 Avenue Therapeutics Reports Second Quarter 2020 Financial Results and Recent Corporate Highlights
